{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:34:19Z","timestamp":1773887659540,"version":"3.50.1"},"reference-count":9,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2097,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1552-6569.2009.00456.x","type":"journal-article","created":{"date-parts":[[2009,12,4]],"date-time":"2009-12-04T15:34:18Z","timestamp":1259940858000},"page":"303-305","source":"Crossref","is-referenced-by-count":28,"title":["MRI Evidence of Early Muscle Atrophy in MuSK Positive Myasthenia Gravis"],"prefix":"10.1111","volume":"21","author":[{"given":"Vasiliki","family":"Zouvelou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rentzos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Toulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Evdokimidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"10.1111\/j.1552-6569.2009.00456.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1111\/j.1552-6569.2009.00456.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/01.LAB.0000028144.48023.9B","article-title":"Anti-P110 autoantibodies identify a subtype of \u2018seronegative\u2019 myasthenia gravis with prominent oculobulbar involvement","volume":"82","author":"Scuderi","year":"2002","journal-title":"Lab Invest"},{"key":"10.1111\/j.1552-6569.2009.00456.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1474-4422(03)00306-5","article-title":"Seronegative generalized myasthenia gravis: clinical features, antibodies and their targets","volume":"2","author":"Vincent","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1111\/j.1552-6569.2009.00456.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1196\/annals.1405.005","article-title":"Clinical phenotype of muscle-specific Tyrosine kinase-antibody-positive Myasthenia Gravis","volume":"1132","author":"Wolfe","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/j.1552-6569.2009.00456.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.wco.0000180660.57801.3f","article-title":"Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis","volume":"18","author":"Vincent","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1111\/j.1552-6569.2009.00456.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","volume":"129","author":"Farrugia","year":"2006","journal-title":"Brain"},{"key":"10.1111\/j.1552-6569.2009.00456.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2005.08.016","article-title":"MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo","volume":"170","author":"Benveniste","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1552-6569.2009.00456.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2006.05.017","article-title":"Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis","volume":"177","author":"Boneva","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1552-6569.2009.00456.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy related-ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"}],"container-title":["Journal of Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1552-6569.2009.00456.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1552-6569.2009.00456.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T10:50:01Z","timestamp":1625655001000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1552-6569.2009.00456.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,4]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1552-6569.2009.00456.x","relation":{},"ISSN":["1051-2284"],"issn-type":[{"value":"1051-2284","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12,4]]}}}